Folate Receptor α - A New Target for an Old Enemy
Ovarian cancer remains one of the biggest challenges in daily gynaeco-oncologic practice due to its high morbidity and mortality. Platinum-based chemotherapy regimens have been the mainstay of advanced ovarian cancer treatment for several decades. However, up to 85% of the patients with advanced dis...
Main Authors: | Katharina Ruf, Ursula Hasler-Strub |
---|---|
Format: | Article |
Language: | English |
Published: |
THE HEALTHBOOK COMPANY LTD.
2020-10-01
|
Series: | healthbook TIMES. Oncology Hematology |
Online Access: | https://doi.org/10.36000/hbT.OH.2020.05.022 |
Similar Items
-
Therapeutic strategies targeting folate receptor α for ovarian cancer
by: Jia Mai, et al.
Published: (2023-08-01) -
From New Molecular Insights to New Treatment Options in Endometrial Cancer
by: Ursula Hasler-Strub
Published: (2022-03-01) -
From New Molecular Insights to New Treatment Options in Endometrial Cancer
by: Ursula Hasler-Strub
Published: (2022-03-01) -
Corrigendum: Therapeutic strategies targeting folate receptor α for ovarian cancer
by: Jia Mai, et al.
Published: (2024-04-01) -
A new role for an old enemy
by: Richard M Monaghan, et al.
Published: (2015-02-01)